aod9604 phase 2 trial results weight loss kg or percent AOD 9604 Peptide for Loss: Weight and Vitality: Medical Weight Loss AOD-9604 Results: Week-by-Week Timeline (2026)

Unlike appetite suppressants that fundamentally alter hunger signals and can lead to undereating, nutrient deficiencies, or rebound hunger, AOD-9604 allows you to follow your chosen dietary protocol whether that is caloric restriction, time-restricted eating, macronutrient tracking, or intuitive eating based on natural hunger cues

The AOD9604 dosage calculator approach considers research objectives, subject characteristics, and protocol duration

The therapy is approved by the FDA and produced under strict quality control

1 Data are medians (quartile 1, quartile 3) or n (%)

a small molecule that remains preclinical and not approved